That's not all. Pomegranate juice works almost as well as cranberry juice against urinary tract infections. And it doesn't cause diarrhea. Cranberry juice can cause diarrhea. I drink about that amount daily and take D-Mannose and Bay glycerite, and that completely works most of the time, and since I have a kidney stone that provides fuel for UTI, this is a real blessing.
The connection between pomegranate's antioxidants and endothelial membrane integrity is fascinating. The polyphenols likely help stabilize cell membranes in arterial walls, which could explain the reduction in intima-media thickness. It's remarkable how natural compounds can support cellular membrane function where pharmaceutical interventions often fall short. Thanks for highlighting this overlooked research!
The Aviram study findings are remarkable - a 35% reduction in IMT from such a modest intervention really challenges the "irreversible progression" narrative in cardiology. What strikes me most is the divergent trajectories: one group reversing, the other progressing, with food being the only variable. The 90% reduction in oxidized LDL is particularly significant given how central oxidative stress is to atherogenesis. It's a compelling example of how nutritional interventions can achieve what pharmaceutical approaches often struggle to accomplish without the associated side effects.
That's not all. Pomegranate juice works almost as well as cranberry juice against urinary tract infections. And it doesn't cause diarrhea. Cranberry juice can cause diarrhea. I drink about that amount daily and take D-Mannose and Bay glycerite, and that completely works most of the time, and since I have a kidney stone that provides fuel for UTI, this is a real blessing.
The connection between pomegranate's antioxidants and endothelial membrane integrity is fascinating. The polyphenols likely help stabilize cell membranes in arterial walls, which could explain the reduction in intima-media thickness. It's remarkable how natural compounds can support cellular membrane function where pharmaceutical interventions often fall short. Thanks for highlighting this overlooked research!
The Aviram study findings are remarkable - a 35% reduction in IMT from such a modest intervention really challenges the "irreversible progression" narrative in cardiology. What strikes me most is the divergent trajectories: one group reversing, the other progressing, with food being the only variable. The 90% reduction in oxidized LDL is particularly significant given how central oxidative stress is to atherogenesis. It's a compelling example of how nutritional interventions can achieve what pharmaceutical approaches often struggle to accomplish without the associated side effects.